EBIT: Income before interest and taxes.
Biogen Inc. (BIIB) had EBIT of $792.70M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$2.65B |
|
$634.80M |
|
$605.00M |
|
$2.04B |
|
$1.85B |
|
$792.70M |
|
$-48.70M |
|
$744.00M |
|
$744.00M |
|
$634.80M |
|
$634.80M |
|
$634.80M |
|
$634.80M |
|
|
EBIT |
$792.70M |
-- |
|
146.50M |
|
146.70M |
|
$4.33 |
|
$4.33 |
|
| Balance Sheet Financials | |
$7.97B |
|
$3.10B |
|
$20.36B |
|
$28.33B |
|
$3.18B |
|
$6.28B |
|
$7.51B |
|
$10.70B |
|
-- |
|
$1.67B |
|
$17.63B |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|